Shanghai Municipal Science and Technology Commission Holds Roundtable Discussion with Foreign-Funded R&D Institutions in Shanghai

MetaMuskRat · 2026-04-02T08:50:31+00:00

The Shanghai Municipal Science and Technology Commission held a roundtable discussion with the China-EU Chamber of Commerce, with representatives from foreign-funded R&D institutions participating to discuss corporate opinions and suggestions. The Municipal Science and Technology Commission pledged to strengthen communication and support, optimize the innovation ecosystem, and assist the development of Shanghai's biopharmaceutical industry.

MetaMuskRat

2026-04-02 08:50:31

Abstract generation in progress

People’s Finance News, April 1—On March 31, the Shanghai Municipal Commission of Science and Technology (STCS) and the European Union Chamber of Commerce in China jointly organized a roundtable exchange meeting for foreign-invested R&D institutions serving in Shanghai.

Representatives from the European Union Chamber of Commerce in China, as well as representatives from six foreign-invested R&D institutions—Novartis, bioMérieux, Siemens Healthineers, DSM-Firmenich, GlaxoSmithKline, and Novo Nordisk—attended. Relevant officials from the STCS departments concerned and colleagues from the Shanghai Science and Technology Exchange Center were also present.

The STCS responded to companies’ related opinions and suggestions, saying it will further strengthen communication and exchange with foreign-invested R&D institutions and align resources, provide policy support with full effort, enhance innovation collaboration, optimize the innovation ecosystem, and help Shanghai’s biopharmaceutical industry achieve high-quality development.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes